-
Published28/07/2026
-
Today12/08/2026
-
Deadline25/08/2026
Utilities
- indicates text translated automatically in your browsing language
LP for autologous cell therapy - ciltakabtagen autoleucel - 2026
Note: Not all information for this procedure were successfully computed. Please consult linked documents for more details.
The subject of the public contract is the supply of a medicinal product intended for the treatment of malignant blood diseases in a total estimated volume of 30 individual doses of the medicinal product. The product is intended for the provision of health care at the health care facility of the University Hospital Pilsen. Deliveries of the subject of performance will be carried out on the basis of the results of the completed procurement procedure for a period of three years from the signing of the purchase contract.
https://tenderarena.cz/profil/fnplzen
https://tenderarena.cz/profil/fnplzen
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.